Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2019

1.2 List of Figures

2.1 Bone Growth Stimulators Overview

3.1 Bone Growth Stimulators - Pipeline Products by Stage of Development
3.2 Bone Growth Stimulators - Pipeline Products by Segment
3.3 Bone Growth Stimulators - Pipeline Products by Territory
3.4 Bone Growth Stimulators - Pipeline Products by Regulatory Path
3.5 Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
3.6 Bone Growth Stimulators - Ongoing Clinical Trials

4.1 Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
4.2 Bone Growth Stimulators - Pipeline Products by Stage of Development

5.1 Bionext Biotech Products Ltd. Company Overview
5.2 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Company Overview
5.3 Curative Biosciences, Inc. Company Overview
5.4 DJO Global Inc Company Overview
5.5 GreenBone Ortho srl Company Overview
5.6 Inion Oy Company Overview
5.7 Johns Hopkins University Company Overview
5.8 KeraCure, Inc. (Inactive) Company Overview
5.9 Lattice Biologics Ltd Company Overview
5.10 NDSU Research Foundation Company Overview
5.11 Oklahoma State University Company Overview
5.12 Orthocell Ltd Company Overview
5.13 Orthofix Medical Inc Company Overview
5.14 OsteoGenix Incorporated (Inactive) Company Overview
5.15 REGENECURE Ltd Company Overview
5.16 Texas A&M University Company Overview
5.17 Tornier Inc Company Overview
5.18 Universiti Putra Malaysia Company Overview
5.19 University of Florida Company Overview
5.20 University of Nottingham Company Overview
5.21 ZetaGen Therapeutics Inc Company Overview
5.22 Zimmer Biomet Holdings Inc Company Overview

6.1 Aug 28, 2019: Medtronic announces planned leadership succession
6.2 Aug 20, 2019: Kuros Biosciences reports results for first half
6.3 Aug 20, 2019: Medtronic reports first quarter financial results for
6.4 Aug 12, 2019: Stryker announces commercial structure realignment
6.5 Aug 01, 2019: Globus Medical reports second quarter 2019 results
6.6 Aug 01, 2019: Integer Holdings reports second quarter 2019 results
6.7 Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results
6.8 Jul 25, 2019: Spineway : Strengthening corporate governance appointment of two new board members
6.9 Jul 25, 2019: Stryker reports second quarter 2019 operating results
6.10 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
6.11 Jul 24, 2019: Kuros announces Gerhard Ries is stepping down as Board member
6.12 Jul 24, 2019: Anika reports second quarter 2019 financial results
6.13 Jul 11, 2019: Spineway : Half-year revenue of €2.6M
6.14 Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning
6.15 Jun 27, 2019: Globus Medical appoints Keith Pfeil as Senior Vice President and CFO
6.16 Jun 20, 2019: Collplant announces corporate name change to Collplant Biotechnologies to better reflect its business
6.17 Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan
6.18 Jun 14, 2019: Stryker to invest €200m in RD&I projects in Ireland
6.19 May 30, 2019: CollPlant reports first quarter 2019 financial results and provides business update
6.20 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
6.21 May 22, 2019: CollPlant Launches New HQ and R&D Center in Israel
6.22 May 02, 2019: Integer Holdings reports first quarter 2019 results
6.23 May 02, 2019: Globus Medical announces first quarter 2019 results
6.24 May 02, 2019: Globus Medical reports first quarter 2019 results
6.25 May 02, 2019: Anika reports first quarter 2019 financial results
6.26 Apr 30, 2019: Kuros Biosciences to propose re-appointment of chairman and board members at Annual General Meeting
6.27 Apr 30, 2019: Anika Therapeutics names Stephen Goldy as vice president of U.S. Sales
6.28 Apr 29, 2019: Spineway: 2018 annual results
6.29 Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results
6.30 Apr 23, 2019: Stryker announces first quarter 2019 operating results
6.31 Apr 12, 2019: Kuros Biosciences reports results for the full year
6.32 Apr 10, 2019: Biologica Technologies exhibits latest foot and ankle arthrodesis data for ProteiOS at The Midwest Podiatry Conference
6.33 Apr 01, 2019: CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
6.34 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer
6.35 Mar 27, 2019: Stryker announces new Vice President, chief legal officer
6.36 Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai
6.37 Mar 18, 2019: Anika Therapeutics names Robert Richard as Vice President of research and development
6.38 Mar 14, 2019: Medtronic names Andrea J. Goldsmith as a new director
6.39 Feb 21, 2019: Globus Medical reports full year and fourth quarter 2018 Results
6.40 Feb 21, 2019: Integer Holdings reports results for fourth quarter and full year
6.41 Feb 21, 2019: Anika reports fourth quarter and full year 2018 financial results
6.42 Feb 19, 2019: Medtronic reports third quarter financial results
6.43 Feb 04, 2019: CollPlant names Jonathan M.N. Rigby as Chairman of the Board
6.44 Feb 01, 2019: Zimmer Biomet announces fourth quarter and full-year 2018 financial results
6.45 Jan 29, 2019: Stryker reports 2018 results and 2019 outlook
6.46 Jan 16, 2019: Spineway: 2018 revenue of €6.5M
6.47 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
6.48 Jan 08, 2019: Globus Medical reports preliminary record fourth quarter and full year sales results
6.49 Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine
6.50 Nov 26, 2018: Osiris Therapeutics names Samson Tom, PhD, MBA to serve as President and Chief Executive Officer
6.51 Nov 20, 2018: Medtronic reports financial results of second quarter of fiscal year
6.52 Nov 20, 2018: Medtronic Reports Second Quarter Financial Results
6.53 Nov 08, 2018: Globus Medical reports third quarter 2018 results
6.54 Nov 08, 2018: Medtronic delivers significant progress on global corporate citizenship efforts
6.55 Nov 07, 2018: Osiris Therapeutics reports third quarter 2018 results
6.56 Nov 01, 2018: Integer Holdings Reports Third Quarter 2018 Results
6.57 Oct 31, 2018: Zimmer Biomet appoints Ivan Tornos as Group President, Orthopedics
6.58 Oct 26, 2018: Zimmer Biomet announces third quarter 2018 financial results
6.59 Oct 25, 2018: Susan M. Stalnecker named to Bioventus Board of Managers
6.60 Oct 25, 2018: Stryker reports third quarter 2018 operating results
6.61 Oct 24, 2018: Anika Therapeutics announces Third Quarter 2018 Financial Results
6.62 Oct 24, 2018: Anika Therapeutics names Susan Vogt as Board Director
6.63 Oct 13, 2018: Johnson Fistel Announces Investigations of Zimmer Biomet Holdings and Acadia Healthcare Company
6.64 Oct 08, 2018: Stryker names Meenakshi Nevatia as New MD for India
6.65 Oct 04, 2018: CelGro used as artificial periosteum repairs bone
6.66 Oct 03, 2018: Osiris Therapeutics announces peer-reviewed publication demonstrating that lyopreservation method developed for living tissues is an alternative to cryopreservation
6.67 Sep 29, 2018: Collplant reports third quarter 2018 financial results and provides business update

7.1 Methodology
7.2 About the Author
7.3 Contact Us
7.4 Disclaimer

Table 1: Bone Growth Stimulators - Pipeline Products by Stage of Development
Table 2: Bone Growth Stimulators - Pipeline Products by Segment
Table 3: Bone Growth Stimulators - Pipeline Products by Territory
Table 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path
Table 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
Table 6: Bone Growth Stimulators - Ongoing Clinical Trials
Table 7: Bone Growth Stimulators Companies - Pipeline Products by Stage of Development
Table 8: Bone Growth Stimulators - Pipeline Products by Stage of Development
Table 9: Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Orthonext - Product Status
Table 11: Orthonext - Product Description
Table 12: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Bioactive Glass Scaffolds - Product Status
Table 14: Bioactive Glass Scaffolds - Product Description
Table 15: Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Nurture BSP - Product Status
Table 17: Nurture BSP - Product Description
Table 18: Osteoconductive Scaffold - Product Status
Table 19: Osteoconductive Scaffold - Product Description
Table 20: DJO Global Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: CMF OL1000 - Fresh Ankle Fracture - Product Status
Table 22: CMF OL1000 - Fresh Ankle Fracture - Product Description
Table 23: DJO Global Inc - Ongoing Clinical Trials Overview
Table 24: CMF OL1000 - Fresh Ankle Fracture - Prospective, Randomized, Double-blinded, Controlled Multi-center Clinical Trial Evaluating the Use of Non-invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures
Table 25: GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview
Table 26: GreenBone Implant - Product Status
Table 27: GreenBone Implant - Product Description
Table 28: GreenBone Ortho srl - Ongoing Clinical Trials Overview
Table 29: GreenBone Implant - A Pre-market Multicenter National Open Label Single Arm Study to Evaluate the Safety and Performance of a Class III Medical Device (Greenbone Implant) for Iliac Crest Reconstruction Following Bone Graft Harvesting for Pelvic Fusion
Table 30: GreenBone Implant - A Pre-market, Multi-center, International, Open-label, Single-arm Study to Evaluate the Safety and Performance of a Class III Medical Device (GreenBone Implant) for Surgical Repair of Long Bone Defects
Table 31: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Inion OptimaPLUS - Product Status
Table 33: Inion OptimaPLUS - Product Description
Table 34: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 35: 3D-printed Bone Extracellular Matrix Scaffold - Product Status
Table 36: 3D-printed Bone Extracellular Matrix Scaffold - Product Description
Table 37: KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 38: KeraPac - Bone Regeneration - Product Status
Table 39: KeraPac - Bone Regeneration - Product Description
Table 40: Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Bone Scaffold + ECM - Product Status
Table 42: Bone Scaffold + ECM - Product Description
Table 43: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Bone Scaffold - Product Status
Table 45: Bone Scaffold - Product Description
Table 46: Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Bone Repair Scaffold - Product Status
Table 48: Bone Repair Scaffold - Product Description
Table 49: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: CelGro SMRT Graft - Bone Repair - Product Status
Table 51: CelGro SMRT Graft - Bone Repair - Product Description
Table 52: Orthofix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Status
Table 54: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Product Description
Table 55: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Status
Table 56: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - Product Description
Table 57: RCStim Device - Product Status
Table 58: RCStim Device - Product Description
Table 59: Orthofix Medical Inc - Ongoing Clinical Trials Overview
Table 60: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - A Multi-center, Open-label, Prospective Study of CervicalStim Device as Adjunctive Care Following Cervical Fusion
Table 61: Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures - Safety and Efficacy of Pulsed Electromagnetic Fields (Cervical-Stim) as an Adjunct to Enhance Union in Conservatively Treated Type II Fractures of the Odontoid Process
Table 62: Physio-Stim Osteogenesis Stimulator - Osteoarthritis - A Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee
Table 63: RCStim Device - Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears
Table 64: OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Bone Anabolic Agent - Product Status
Table 66: Bone Anabolic Agent - Product Description
Table 67: REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Regenecure AMCA GBR Bone Membrane Implant - Product Status
Table 69: Regenecure AMCA GBR Bone Membrane Implant - Product Description
Table 70: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Bioactive Foam Based Moldable Scaffold - Product Status
Table 72: Bioactive Foam Based Moldable Scaffold - Product Description
Table 73: Tornier Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Soft Tissue Graft - Product Status
Table 75: Soft Tissue Graft - Product Description
Table 76: Universiti Putra Malaysia Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Nanocomposite Bone Scaffold - Product Status
Table 78: Nanocomposite Bone Scaffold - Product Description
Table 79: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Bone Tissue Scaffold - Product Status

Figure 1: Bone Growth Stimulators - Pipeline Products by Stage of Development
Figure 2: Bone Growth Stimulators - Pipeline Products by Segment
Figure 3: Bone Growth Stimulators - Pipeline Products by Territory
Figure 4: Bone Growth Stimulators - Pipeline Products by Regulatory Path
Figure 5: Bone Growth Stimulators - Pipeline Products by Estimated Approval Date
Figure 6: Bone Growth Stimulators - Ongoing Clinical Trials